Julie Yoo

Investment Partner, a16z

Boston

Julie is a Partner at Andreessen Horowitz, focused on digital health investments out of the a16z Bio fund. Prior to a16z, she was Co-Founder and Chief Product Officer of Kyruus, where she wrote the first version of what ultimately became Kyruus’s market-leading patient access product platform. Julie previously ran product at Generation Health from inception through acquisition by CVS Health, and Knome, the world's first whole genome sequencing service for private individuals. Julie’s career in tech began as an early member of the software engineering team at Endeca Technologies (acquired by Oracle). She studied computer science and pre-medicine as an undergrad at MIT, and obtained an MS and MBA from Harvard-MIT HST and MIT Sloan. Outside of Kyruus, Julie is a Young Global Leader with the World Economic Forum, and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health.